These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9741911)
41. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles. Zhou Z; Li L; Yang Y; Xu X; Huang Y Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427 [TBL] [Abstract][Full Text] [Related]
42. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer. Kopansky E; Shamay Y; David A J Drug Target; 2011 Dec; 19(10):933-43. PubMed ID: 22074249 [TBL] [Abstract][Full Text] [Related]
43. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics. Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676 [TBL] [Abstract][Full Text] [Related]
44. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death. Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609 [TBL] [Abstract][Full Text] [Related]
45. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate. Sivak L; Subr V; Tomala J; Rihova B; Strohalm J; Etrych T; Kovar M Biomaterials; 2017 Jan; 115():65-80. PubMed ID: 27886555 [TBL] [Abstract][Full Text] [Related]
46. The effects of subcellular localization of N-(2-hydroxypropyl)methacrylamide copolymer-Mce(6) conjugates in a human ovarian carcinoma. Tijerina M; Kopecková P; Kopecek J J Control Release; 2001 Jul; 74(1-3):269-73. PubMed ID: 11489506 [TBL] [Abstract][Full Text] [Related]
47. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370 [TBL] [Abstract][Full Text] [Related]
48. Synthesis of poly[N-(2-hydroxypropyl)methacrylamide] conjugates of inhibitors of the ABC transporter that overcome multidrug resistance in doxorubicin-resistant P388 cells in vitro. Subr V; Sivák L; Koziolová E; Braunová A; Pechar M; Strohalm J; Kabešová M; Ríhová B; Ulbrich K; Kovář M Biomacromolecules; 2014 Aug; 15(8):3030-43. PubMed ID: 24978588 [TBL] [Abstract][Full Text] [Related]
49. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting. Li L; Yang Q; Zhou Z; Zhong J; Huang Y Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960 [TBL] [Abstract][Full Text] [Related]
50. Comparative Endocytosis Mechanisms and Anticancer Effect of HPMA Copolymer- and PAMAM Dendrimer-MTCP Conjugates for Photodynamic Therapy. Mohammadpour R; Safarian S; Buckway B; Ghandehari H Macromol Biosci; 2017 Apr; 17(4):. PubMed ID: 27779358 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma. Minko T; Kopecková P; Kopecek J Int J Cancer; 2000 Apr; 86(1):108-17. PubMed ID: 10728603 [TBL] [Abstract][Full Text] [Related]
53. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance. Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991 [TBL] [Abstract][Full Text] [Related]
54. Antisense oligonucleotides delivered to the lysosome escape and actively inhibit the hepatitis B virus. Jensen KD; Kopecková P; Kopecek J Bioconjug Chem; 2002; 13(5):975-84. PubMed ID: 12236779 [TBL] [Abstract][Full Text] [Related]
55. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282 [TBL] [Abstract][Full Text] [Related]
56. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat. Yeung TK; Hopewell JW; Simmonds RH; Seymour LW; Duncan R; Bellini O; Grandi M; Spreafico F; Strohalm J; Ulbrich K Cancer Chemother Pharmacol; 1991; 29(2):105-11. PubMed ID: 1760851 [TBL] [Abstract][Full Text] [Related]
57. Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity. Mrkvan T; Sirova M; Etrych T; Chytil P; Strohalm J; Plocova D; Ulbrich K; Rihova B J Control Release; 2005 Dec; 110(1):119-29. PubMed ID: 16269198 [TBL] [Abstract][Full Text] [Related]
58. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Tomalova B; Sirova M; Rossmann P; Pola R; Strohalm J; Chytil P; Cerny V; Tomala J; Kabesova M; Rihova B; Ulbrich K; Etrych T; Kovar M J Control Release; 2016 Feb; 223():1-10. PubMed ID: 26708020 [TBL] [Abstract][Full Text] [Related]
59. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. Etrych T; Jelínková M; Ríhová B; Ulbrich K J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062 [TBL] [Abstract][Full Text] [Related]
60. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]